Comparison of PACT-Q2 scores of dabigatran group versus VKA group
| PACT-Q2 dimensions | No of matched patient sets | Dabigatran group (mean±SD) | VKA group (mean±SD) | P value (dabigatran vs VKA) |
| Convenience dimension score | ||||
| Visit 2 | 217 | 78.4±14.6 | 75.1±19.6 | 0.0423 |
| Visit 3 | 157 | 80.4±13.6 | 76.0±18.9 | 0.0287 |
| Satisfaction dimension score | ||||
| Visit 2 | 217 | 61.5±12.7 | 59.9±13.5 | 0.2226 |
| Visit 3 | 157 | 63.9±11.6 | 60.9±12.8 | 0.0300 |
Bold p value indicates significance.
PACT-Q2, perception on anticoagulant treatment questionnaire-2; VKA, vitamin K antagonists.